| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | Aug 25, 2025 | DYNAVAX TECHNOLOGIES CORP | Director | Buy | 91.3 | +3,800 | 12.18% | ✗ | $41.1K |
| Apr 30, 2025 | Apr 30, 2025 | Zentalis Pharmaceuticals, Inc. | Director | Buy | 86.3 | +21,000 | 8.07% | ✗ | $29.4K |
| Apr 12, 2023 | Apr 12, 2023 | Viridian Therapeutics, Inc.\DE | CEO | Buy | 82.5 | +4,000 | 1.57% | ✗ | $101.5K |
| Mar 13, 2023 | Mar 13, 2023 | Viridian Therapeutics, Inc.\DE | CEO | Buy | 82.5 | +5,500 | 2.20% | ✗ | $160.3K |